| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |